Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Chemidex Pharma Limited, Chemidex House, Egham Business Village, Crabtree Road, Egham, Surrey TW20 8RB, United Kingdom
Ponstan Forte Tablets 500 mg.
Pharmaceutical Form |
---|
Film-coated tablet. Yellow, biconvex elliptical film coated tablet, inscribed ‘Ponstan Forte’ on one side. |
Each tablet contains 500 mg mefenamic acid.
Excipients with known effect: Each tablet contains 22.73 mg lactose monohydrate, and 0.067 mg sunset yellow (E110).
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Mefenamic acid |
Mefenamic acid is a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic and antipyretic properties. |
List of Excipients |
---|
Tablet core: Lactose monohydrate Coating (Opadry OY-LS-22808): Hypromellose Polish: (Opaglos AG7350): Beeswax, white |
a) Aluminium foil/pvc blister pack in cardboard carton. Pack sizes: 28 and 100 tablets.
b) HDPE DUMA and polypropylene container. Pack sizes: 100 and 500 tablets.
c) Amber polystyrene bottle with a high density polyethene anti-arthritic closure. Pack sizes: 6, 12, 84, 100 and 500 tablets.
Not all pack sizes may be marketed.
Chemidex Pharma Limited, Chemidex House, Egham Business Village, Crabtree Road, Egham, Surrey TW20 8RB, United Kingdom
PL 17736/0007
10/10/2005
Drug | Countries | |
---|---|---|
PONSTAN | Australia, Brazil, Cyprus, Hong Kong, Ireland, Mexico, Nigeria, New Zealand, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.